СORRECTION FEATURES OF THE GENITOYRINARY SYNDROME OF MENOPAUSE
DOI:
https://doi.org/10.11603/24116-4944.2017.2.7579Keywords:
genitourinary syndrome of menopause, genitourinary dysfunction, vaginal health index, stress urinary incontinence.Abstract
The aim of the study – to determine the clinical efficacy of complex drug therapy to correct the genitourinary syndrome of menopause.
Materials and methods. There were examined 50 women aged 49–57 with menopausal genitourinary disorders. The patients were divided into two groups. The patients of the main group received the estrogen – containing drug, phytouroseptic and homeopathic medicine that regulate rhythmic processes in CNS. The patients of the comparison group were administered the estrogen – containing drug and phytouroseptic. All patients underwent routine clinical and laboratory examination. The degree of manifestation of the urogenital disorders was assessed by the vaginal health Index by the criteria of G.Bochman, D. Barlow scale, daily Pad-test by the ICS standards.
Results and discussion. In determining the vaginal health Index in 29 (58 %) patients were revealed moderate signs of genitourinary disorders (3 points), 21 (42 %) had weak disorders (4 points), on an average – 3.42 ± 0.50 points. It was established that before treatment the majority of patients – 36 (72 %) assessed their condition as “significant recurrent problem that affects everyday life” (3 points), 14 (28 %) patients described it as “discomfort, which periodically impact on daily life” (2 points), on an average – 2.72 ± 0.45 points. The stage I of incontinence was observed in 47 (94 %) women examined, the stage II – in 3 (6 %). The proposed scheme of drug therapy aimed at correcting major pathogenetic links of urogenital menopausal syndrome formation is not long-term, but quite effective and safe for women of the menopausal age.
Conclusions. Inclusion of drugs in treatment of urogenital menopausal syndrome that regulate rhythmic processes in the
pathogenesis of CNS is justified and promising.
References
Kalugina, L.V., Tatarchuk, T.F., & Zanko, O.V. (2016). Genitourinarnyy menopauzalniy sindrom – problema zhenshchin elegantnogo vozrasta i ne tolko [Genitourinary menopausal syndrome – problem for women of elegant age and not only]. Reproduktivna endokrinologіya – Reproductive endocrinology, 2(28), 68-74 [in Russian].
Barlow, D.H., Samsioe, G., & van Geelen I.M. (1997). A study of European women experience of the problems of
urogenital aging and its management. Maturitas, 27 (3), 239-247.
Stolyarova, U.V., & Khvorostukhina, N.F. (2013). Psikhoemotsionalnye narusheniya pri klimaktericheskom sindrome [Psychoemotional violations in menopausal syndrome]. Fundamentalnye issledovaniya – Fundamental research, 9 (1), 202-206 [in Russian].
Smetnik V.P. (2009). Meditsina klimakteriya [Medicine of climacterium]. Yaroslavl: Litera [in Russian].
Bachmann, G., Lobo, r.a., & Gut r. (2008). Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet. Gynecol., 111, (1). 67-76.
Abrams, P., Andersson, K. E., Birder, L., Brubaker, L., Cardozo, L., & Chapple, C. Fourth international consultation
on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol. Urodyn. 29(1), 213-240.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).
